Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial Academic Article uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Anticoagulants
  • Coronary Disease
  • Enoxaparin
  • Heparin
  • Platelet Glycoprotein GPIIb-IIIa Complex

abstract

  • In high-risk patients undergoing early percutaneous coronary intervention for acute coronary syndrome, enoxaparin avoids the need for monitoring and achieves similar effectiveness to UFH but is associated with more bleeding.

publication date

  • December 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ahj.2006.08.002

PubMed ID

  • 17161049

Additional Document Info

start page

  • 1042

end page

  • 50

volume

  • 152

number

  • 6